Skip to content

Dr. Inge De Latte

Active
Private limited companyfounded 200817 yrs activeKeibergkerkweg 38, 9340 Lede, BelgiumKBO/BCE: BE 0808.485.496

Dr. Inge De Latte has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €2.11M and a net result of €593k. Equity is growing by ~15.7% per year across the filed fiscal years. Its solvency ranks better than 64% of 2152 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2024
88 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability95▼-1
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €180k at 30 days acceptable
Liquidity ample (current ratio 3.99 against 4.32 in 2023; short-term debt: 24% and cash: 11.2% of total assets), and 24.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
75.7%
Return on assets
21.2%
Age of the figures
21 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-10-2025, 82 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
82 d late
2023
61 d late
2022
70 d late
2021
110 d late
2020
30 d late
2019
122 d late
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, abbreviated schema

Equity
€2.11M▲ 27.4%
2023 · €1.66M
2018: €820k 2019: €1.12M 2020: €1.29M 2021: €959k 2022: €1.26M 2023: €1.66M
2018 → 2024
Total assets
€2.79M▲ 30.3%
2023 · €2.14M
2018: €1.45M 2019: €1.72M 2020: €2.00M 2021: €1.58M 2022: €2.15M 2023: €2.14M
2018 → 2024
Net result
€593k▲ 25.2%
2023 · €474k
2018: €138k 2019: €299k 2020: €175k 2021: €165k 2022: €384k 2023: €474k
2018 → 2024
Working capital
€2.00M▲ 26.5%
2023 · €1.58M
2018: €732k 2019: €1.06M 2020: €1.26M 2021: €924k 2022: €1.22M 2023: €1.58M
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€1.29M-€959k▼ 25.9%€1.26M▲ 31.7%€1.66M▲ 31.2%€2.11M▲ 27.4%
Operating result€254k-€236k▼ 6.9%€563k▲ 138%€676k▲ 20.1%€836k▲ 23.7%
Net result€175k-€165k▼ 5.9%€384k▲ 133%€474k▲ 23.3%€593k▲ 25.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€250k€500k€750kOperating result 2020: €254k€254kNet result 2020: €175k€175kOperating result 2021: €236k€236kNet result 2021: €165k€165kOperating result 2022: €563k€563kNet result 2022: €384k€384kOperating result 2023: €676k€676kNet result 2023: €474k€474kOperating result 2024: €836k€836kNet result 2024: €593k€593k20202021202220232024
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 24% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €2.79M
Fixed assets €120k▲ 43.7%
Current assets €2.67M▲ 29.7%
Equity and liabilities €2.79M
Equity €2.11M▲ 27.4%
Debt €679k▲ 40.1%
The debt ratio rises from 22.6% to 24.3%. Equity and debt are higher.
Key figures and ratios
2024 value · change against 2023
EBITDA
€856k
2023 · €694k
Cash flow
€613k
2023 · €492k
Solvency
75.7%
2023 · 77.4%
Current ratio
3.99
2023 · 4.32
Quick ratio
3.89
2023 · 4.13
Debt / equity
0.32
2023 · 0.29
ROE
28.1%
2023 · 28.6%
ROA
21.2%
2023 · 22.1%
Interest coverage
1712.99
2023 · 2896.88
Debt
€679k
2023 · €484k
Debt ≤ 1 year
€669k
2023 · €476k
Income taxes
€276k
2023 · €221k
Staff costs
€78k
2023 · €58k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€2.14M€2.79M
Fixed assets21/28€84k€120k
Intangible fixed assets21€5k€4k
Tangible fixed assets22/27€77k€115k
Plant, machinery and equipment23€15k€12k
Furniture and vehicles24€51k€53k
Other tangible fixed assets26€11k€50k
Financial fixed assets28€1k€2k
Current assets29/58€2.06M€2.67M
Amounts receivable after more than one year29€212k€212k=
Other amounts receivable291€212k€212k=
Stocks and contracts in progress3€91k€69k
Stocks30/36€91k€69k
Amounts receivable within one year40/41€999k€1.32M
Trade receivables40€328k€483k
Other amounts receivable41€671k€839k
Current investments50/53€2k€752k
Cash at bank and in hand54/58€751k€312k
Deferred charges and accrued income490/1€3k€1k
Equity and liabilities
Total equity and liabilities10/49€2.14M€2.79M
Equity10/15€1.66M€2.11M
Contributions10/11€19k€19k=
Reserves13€1.64M€2.09M
Distributable reserves133€1.64M€2.09M
Amounts payable17/49€484k€679k
Amounts payable within one year42/48€476k€669k
Financial debts43€280€3k
Credit institutions430/8€280€3k
Trade debts44€47k€111k
Suppliers440/4€47k€111k
Taxes, remuneration and social security45€148k€176k
Taxes450/3€138k€162k
Remuneration and social security454/9€10k€14k
Other amounts payable47/48€281k€379k
Accrued charges and deferred income492/3€8k€10k
Income statement Code20232024
Non-recurring operating income76A-€442
Remuneration, social security and pensions62€58k€78k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€18k€20k
Other operating charges640/8€5k€4k
Gross operating margin9900€757k€939k
Operating profit (loss)9901€676k€836k
Financial income75/76B€19k€33k
Recurring financial income75€19k€33k
Financial charges65/66B€240€500
Recurring financial charges65€240€500
Profit (loss) for the period before taxes9903€695k€869k
Income taxes67/77€221k€276k
Profit (loss) for the period9904€474k€593k
Profit (loss) for the period to be appropriated9905€474k€593k
Appropriation of the result
Profit (loss) to be appropriated9906€474k€593k
Transfer from equity791/2€80k€138k
Transfer to equity691/2€474k€593k
To other reserves6921€474k€593k
Profit to be distributed694/7€80k€138k
Return on contributions (dividend)694€80k€138k
Social balance
Average headcount (FTE)90873.03.0=

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
21-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 82 days late
2024
31-12
Financial Highest result since 2018net €593k ▲25.2%
Operating result €836k, net result €593k, both a record.
31-12
Financial Equity above €2MEq €2.11M ▲27.4%
7 profitable years in a row build equity to €2.11M.
30-09
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 61 days late
2023
09-10
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 70 days late
2022
31-12
Financial Equity above €1MEq €1.26M ▲31.7%
5 profitable years in a row build equity to €1.26M.
18-11
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 110 days late
2021
30-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 30 days late
2020
30-11
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 122 days late
2019
31-12
Financial Equity above €1MEq €1.12M ▲36.5%
2 profitable years in a row build equity to €1.12M.
30-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 30 days late
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 31 days late
2017
30-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 30 days late
2016
31-08
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lede · 3 establishment units since 2008
establishment All 3 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Keibergkerkweg 389340 Lede
Ground area
2.7 ha
Building footprint
1.5 ha
Volume, LiDAR
185,111 m³
4 parcels, Flanders · tallest building 27.4 m, ±5 floors. Linked by address, not a title deed.
3 establishment units
Groenebriel 1, 9000 Gent
Specialist medical practice
since 20082.228.979.925
Ferdinand Lousbergskaai 103, 9000 Gent
Specialist medical practice
since 20132.237.413.381
Nieuwstraat 11, 9340 Lede
Specialist medical practice
since 20232.348.880.041
4 parcels
Flanders 4 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44021A1459/00X000 Flanders 1.9 ha 1 · 1.0 ha 27.4 m · 5 fl.
44804D3609/00W000 Flanders 6,639 m² 1 · 4,129 m² 16.3 m · 5 fl.
41034C0266/00F000 Flanders 1,464 m² 1 · 430 m² 8.9 m · 2 fl.
41034F0985/00E000 Flanders 158 m² 1 · 158 m² 11.5 m · 1 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 3
4 of 4 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,628 companies in sector 86220 we hold annual accounts for 7,972. 4,518 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded17-12-2008
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 16 filingsAddress and cadastre registers

Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

2 entries
E-mail:inge.delatte@azstlucas.be
Establishment Gent 2.228.979.925
Phone:092246662
Establishment Gent 2.228.979.925